Non-targeted HIV testing in emergency departments identifies only few new cases, study finds

October 24, 2011, JAMA and Archives Journals

Non-targeted HIV rapid test screening among emergency department patients in metropolitan Paris resulted in identifying only a few new HIV diagnoses, often at late stages and mostly among patients who are in a high-risk group, according to a study published Online First by the Archives of Internal Medicine.

"During the last 15 years, (HIV) screening combined with early treatment has effectively reduced HIV-related mortality, and some authors have postulated that this strategy plays a key role in controlling the epidemic," the authors write as background information in the article. Late diagnoses remains common even though there is free HIV testing in France. "To lower the number of undiagnosed infections and to improve early detection, nontargeted HIV rapid test (RT) screening in health care settings has been promoted by national health agencies in the United States, the United Kingdom, and, more recently, France." They add, "In France, because an estimated 25 percent of inhabitants (14 million) visit an ED [] annually, EDs appear to be an ideal setting to assess nontargeted HIV-RT screening of the general population.

Kayigan Wilson d'Almeida, M.D., and colleagues from the Emergency Department HIV-Screening Group in France, conducted an interventional study in 29 emergency departments from May 2009 through September 2010 that lasted for six consecutive weeks, which were randomly assigned. During that time at the participating emergency departments, 18- to 64-year-old who were able to provide consent for HIV testing were offered a fingerstick whole-blood HIV RT. "Main outcome measures were the number of patients tested for HIV and their characteristics vs those of the general metropolitan Paris population and the proportion of newly diagnosed HIV-positive patients among those tested and their characteristics vs those from the national HIV case surveillance."

"Among 138,691 visits, there were 78,411 eligible patients, 20,962 of whom (27 percent) were offered HIV RT; 13,229 (63.1 percent) accepted testing and 12,754 (16.3 percent) were tested," the authors report. "The ED patients' characteristics reflected the general population distribution. Eighteen patients received new HIV diagnoses (0.14 percent)." The authors note that the average age of the patients with the newly diagnosed infection was 32.9 years. Of these patients, "12 (66.7 percent) reported previous HIV testing (median [midpoint] time since the last HIV test, one year), seven (39 percent) were men who reported having sex with men, and 10 (55 percent) were heterosexuals from sub-Saharan Africa."

"In conclusion, ED-based HIV RT screening is feasible and can reach large numbers of patients. However, unexpectedly, nontargeted screening identified only a few new diagnoses, often already at late stages, and most newly diagnosed patients belonged to a high-risk group and had been tested previously. Therefore, our observations do not support the implementation of nontargeted HIV screening of the general population in Eds."

In an invited commentary accompanying the article, Jason S. Haukoos, M.D., M.Sc., from Denver Health Medical Center, Denver, Colo., writes: "Early identification of human immunodeficiency (HIV) infection remains a critical public health priority. In the United States, approximately 240,000 individuals remain undiagnosed and 56,000 new infections occur annually."

Dr. Haukoos notes that the "Centers for Disease Control and Prevention (CDC) has recommended 'routine' (nontargeted) opt-out HIV in healthcare settings, including emergency departments (EDs) because EDs are considered the most common site of missed opportunities for diagnosing HIV infection."

"Rigorous, large-scale, comparative effectiveness research is needed to understand how best to identify patients with undiagnosed HIV infection. In the end, the use of targeted strategies may still help prioritize HIV testing and prevention resources where the epidemic is concentrated."

Explore further: Study shows missed opportunities for HIV diagnosis in emergency departments

More information: Arch Intern Med. Published online October 24, 2011. doi:10.1001/archinternmed.2011.535

Related Stories

Study shows missed opportunities for HIV diagnosis in emergency departments

July 29, 2011
New University of Cincinnati (UC) research on HIV testing at local emergency departments shows that hospitals miss opportunities to diagnose patients who do not know they are infected with HIV, even when a regular testing ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.